SaraSooheeKimMD

PubMed

• A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancer.
  Bangi, E.,Ang, C.,Smibert, P.,Uzilov, A. V.,Teague, A. G.,Antipin, Y.,Chen, R.,Hecht, C.,Gruszczynski, N.,Yon, W. J.,Malyshev, D.,Laspina, D.,Selkridge, I.,Rainey, H.,...> ;Sci Adv. 2019 May 28
• A case of syngeneic graft-versus-host disease.
  Patel, S. U.,Yum, K.,Kim, S.,Isola, L. M.,Scigliano, E.,Jakubowski, R.,Park, D.> ;J Oncol Pharm Pract. 2018 Oct 16
• A single-center, retrospective analysis to compare the efficacy and safety of filgrastim-sndz to filgrastim for prophylaxis of chemotherapy-induced neutropenia and for...
  Zecchini, J.,Yum, K.,Steinberg, A.,Smith, C.,Kim, S.> ;Support Care Cancer. 2017 Oct 11
• Severe post-treatment leukopenia associated with the development of encephalopathy following ifosfamide infusion.
  Kim, S. S.,Isola, L. M.,Oh, W. K.> ;Anticancer Drugs. 2015 Dec 03
• A review of a novel, Bruton's tyrosine kinase inhibitor, ibrutinib.
  Lee, C. S.,Rattu, M. A.,Kim, S. S.> ;J Oncol Pharm Pract. 2014 Nov 27
• Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options.
  Kim, S. S.,Patel, M.,Yum, K.,Keyzner, A.> ;Transfusion. 2014 Sep 12
• Pharmacoeconomic impact of up-front use of plerixafor for autologous stem cell mobilization in patients with multiple myeloma.
  Kim, S. S.,Renteria, A. S.,Steinberg, A.,Banoff, K.,Isola, L.> ;Cytotherapy. 2014 Jun 15
• Treatment options in steroid-refractory acute graft-versus-host disease following hematopoietic stem cell transplantation.
  Kim, S.S.> ;Ann Pharmacother. 2007 Sep
• 17 citations
  Upregulation of hepatic LDL receptor-related protein in nephrotic syndrome: response to statin therapy.
  Sara Kim, Choong H. Kim, Nosratola D. Vaziri> ;American Journal of Physiology. Endocrinology and Metabolism. 2005 Apr 1
• Role of fluoxetine in anorexia nervosa.
  Kim, S.S.> ;Ann Pharmacother. 2003 Jun
• Join now to see all